Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Lancet. Neurology|April 19, 2025
Amyotrophic lateral sclerosis caused by TARDBP mutations: from genetics to TDP-43 proteinopathyRubika Balendra, Jemeen Sreedharan, Martina Hallegger, et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration|October 10, 2019
An epidemiological profile of dysarthria incidence and assistive technology use in the living population of people with MND in ScotlandElizabeth Elliott, Judith Newton, Phillipa Rewaj, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
Machine learning identifies routine blood tests as accurate predictive measures of pollution-dependent poor cognitive functionHamish Johnson, James Longden, Gary Cameron, et al.
The Journal of Pathology|October 4, 2019
Dysregulation of AMPA receptor subunit expression in sporadic ALS post-mortem brainJenna M Gregory, Matthew R Livesey, Karina McDade, et al.
Brain : a Journal of Neurology|September 5, 2025
Genotype-specific interferon signatures in amyotrophic lateral sclerosis relate to disease severityOlga Carletta, Camilla Perfetto, Olivia M Rifai, et al.
The Journal of Pathology|December 9, 2021
NLRP3 inflammasome as a key molecular target underlying cognitive resilience in amyotrophic lateral sclerosisPoulomi Banerjee, Elizabeth Elliott, Olivia M Rifai, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|September 23, 2025
Quantitative Profiling of Nanoscopic Protein Aggregates Reveals Specific Fingerprint of TDP-43-Positive Assemblies in Motor Neuron DiseaseDezerae Cox, Melanie Burke, Sara Milani, et al.
Brain Communications|March 6, 2020
Targeting mitochondrial dysfunction in amyotrophic lateral sclerosis: a systematic review and meta-analysisArpan R Mehta, Rachel Walters, Fergal M Waldron, et al.
Frontiers in Molecular Neuroscience|April 5, 2021
40 Years of CSF Toxicity Studies in ALS: What Have We Learnt About ALS Pathophysiology?Koy Chong Ng Kee Kwong, Pratap K Harbham, Bhuvaneish T Selvaraj, et al.
Pageof 5